| abstract |
The present invention relates generally to the field of skin care products and more particularly to topical skin applications containing an imidazole compound and, preferably, a zinc compound for treatment of skin inflammation and/or increased transepidermal water loss associated with non-microbial skin conditions. The present invention may be embodied in creams, lotions, oils, sprays and other typical dosage forms for direct application to the skin. |